how does semaglutide reduce inflammation more than appetite—it works across several organs that influence metabolic health. Clinical studies show that semaglutide can: 🧠 Improve appetite regulation through brain pathways 🩸 Reduce within the Dr. - 🧬 Could a

Testing: Third-party lab report available where provided

DVT was not a pre-specified endpoint in SUSTAIN-6

doi:10.1097/AOG.0000000000003500 Simon JA, Kingsberg SA, Portman D, et al

The SELECT trial (17,000+ adults with overweight/obesity and heart disease, but no diabetes) showed semaglutide reduced major cardiovascular events by 20% and a portion of that benefit didnt correlate with how much weight participants lost

The FLOW trial achieved its primary endpoint with Ozempic 1mg, demonstrating a statistically significant and superior 24% relative risk reduction of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease (4.9% absolute risk reduction at three years) compared to placebo, when added to standard of care